...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >14,15-epoxyeicosatrienoic acid represents a transferable endothelium-dependent relaxing factor in bovine coronary arteries.
【24h】

14,15-epoxyeicosatrienoic acid represents a transferable endothelium-dependent relaxing factor in bovine coronary arteries.

机译:14,15-环氧二十碳三烯酸代表牛冠状动脉中的一种可转移的内皮依赖性舒张因子。

获取原文
获取原文并翻译 | 示例

摘要

Bradykinin causes arterial relaxation and hyperpolarization, which is mediated by a transferable endothelium-derived hyperpolarizing factor (EDHF). In coronary arteries, epoxyeicosatrienoic acids (EETs) are involved in the EDHF response. However, the role of EETs as transferable mediators of EDHF-dependent relaxation remains poorly defined. Two small bovine coronary arteries were cannulated and perfused in tandem in the presence of the nitric oxide synthase inhibitor, nitro-L-arginine (30 micromol/L), and the cyclooxygenase inhibitor, indomethacin (10 micromol/L). Luminal perfusate from donor arteries with intact endothelium perfused endothelium-denuded detector arteries. Detector arteries were constricted with U46619 and diameters were monitored. Bradykinin (10 nmol/L) added to detector arteries did not induce dilation (5+/-2%), whereas bradykinin addition to donor arteries dilated detector arteries by 26.5+/-7% (P<0.05). These dilations were blocked by donor artery endothelium removal and detector artery treatment with the EET-selective antagonist, 14,15-epoxyeicosa-5(Z)-monoenoic acid (14,15-EEZE; 10 micromol/L, -5+/-6%) but not 14,15-EEZE treatment of donor arteries (20+/-5%). 14,15-EET (0.1 to 10 micromol/L) added to detector arteries induced maximal dilations of 82+/-5% that were inhibited 50% by detector artery treatment with 14,15-EEZE (32+/-12%) but not donor artery treatment with 14,15-EEZE. Liquid chromatography-electrospray ionization mass spectrometry analysis verified the presence of 14,15-EET in the perfusate from an endothelium-intact but not denuded artery. These results show that bradykinin stimulates donor artery 14,15-EET release that dilates detector arteries. 14,15-EEZE blocked the donor artery, endothelium-dependent, bradykinin-induced relaxations, and attenuated relaxations to 14,15-EET. These results suggest that EETs are transferable EDHFs in coronary arteries.
机译:缓激肽引起动脉松弛和超极化,这由可转移的内皮衍生的超极化因子(EDHF)介导。在冠状动脉中,环氧二十碳三烯酸(EET)参与EDHF反应。然而,EET作为依赖EDHF的舒张剂的可转移介质的作用仍然不清楚。在存在一氧化氮合酶抑制剂硝基-L-精氨酸(30 micromol / L)和环氧合酶抑制剂吲哚美辛(10 micromol / L)的情况下,串联插入两个小牛冠状动脉并进行灌注。来自供体动脉的荧光灌洗液与完整的内皮细胞灌注了内皮剥脱的检测器动脉。用U46619收缩检测器动脉,并监测直径。添加到检测器动脉的缓激肽(10 nmol / L)不引起扩张(5 +/- 2%),而添加到供体动脉的缓激肽使检测器动脉扩张26.5 +/- 7%(P <0.05)。这些扩张被供体动脉内皮去除和用EET选择性拮抗剂14,15-epoxyeicosa-5(Z)-monoenoic acid(14,15-EEZE; 10 micromol / L,-5 +/- 6%),但不进行供体动脉的14,15-EEZE治疗(20 +/- 5%)。向检测器动脉中添加14,15-EET(0.1至10 micromol / L)引起的最大扩张为82 +/- 5%,而通过14,15-EEZE(32 +/- 12%)的检测器动脉治疗抑制了50%但未使用14,15-EEZE进行供体动脉治疗。液相色谱-电喷雾电离质谱分析验证了来自完整内皮但未剥除动脉的灌注液中14,15-EET的存在。这些结果表明缓激肽刺激供体动脉14,15-EET释放,从而扩张了检测器的动脉。 14,15-EEZE阻断供体动脉,内皮依赖性,缓激肽诱导的舒张,并减弱至14,15-EET的舒张。这些结果表明,EET是冠状动脉中可转移的EDHF。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号